Table 5.

The SAQ results before (day 0) and after (day 30) treatment

Mean ± SD	Group				p-valuea
	A	B	C	D
Physical limitation
Baseline	20.30 ± 2.49	20.0 ± 6.14	20.80 ± 5.24	25.40 ± 3.24	0.04
End	35.20 ± 4.96***	36.80 ± 2.48***	37.0 ± 4.61***	23.70 ± 5.01	< 0.001
Discord	↑14.90 ± 6.75***	↑16.80 ± 8.11***	↑16.20 ± 5.97***	1.7 ± 4.62	< 0.001
p-valueb	0.001	0.001	0.001	0.28	-
Angina stability
Baseline	2.70 ± 1.33	2.0 ± 1.15	2.30 ± 0.94	4.0 ± 0.66	0.001
End	5.40 ± 0.96	5.40 ± 0.69	5.30 ± 0.82	4.30 ± 1.82	0.11
Discord	↑2.70 ± 0.95***	↑3.40 ± 0.96***	↑3.0 ± 0.97***	↑0.30 ± 2.32	< 0.001
p-valueb	0.001	0.001	0.001	0.68	-
Angina frequency
Baseline	5.0 ± 1.88	4.30 ± 2.54	4.40 ±2.06	8.0 ± 2.44	0.002
End	10.70 ± 1.25*	10.1 ± 1.52	10.0 ± 0.66	8.4 ± 2.59	0.02
Discord	↑5.70 ± 1.70***	↑5.8 ± 0.96***	↑5.60 ± 2.12***	↑0.40 ± 3.80	< 0.001
p-valueb	0.001	0.001	0.001	0.74	-
Treatment satisfaction
Baseline	8.40 ± 1.98	7.10 ± 2.55	7.30 ± 2.31	8.70 ± 2.0	0.30
End	18.70 ± 2.98***	18.80 ± 1.8***	7.40 ± 1.83***	12.20 ± 4.10	< 0.001
Discord	↑10.30 ± 3.50***	↑11.70 ± 3.71***	↑4.40 ± 1.77***	↑3.50 ± 5.20	< 0.001
p-valueb	0.001	0.001	0.001	0.07	-
Disease perception
Baseline	2.90 ± 0.87	2.30 ± 0.65	3.0 ± 1.94	2.9 ± 1.3	0.63
End	7.90 ± 1.10***	6.80 ± 1.3***	7.40 ± 1.83***	3.9 ± 2.51	< 0.001
Discord	↑5.0 ± 1.56***	↑4.50 ± 0.97***	↑4.40 ± 1.77***	↑1.0 ± 2.54	< 0.001
p-valueb	0.001	0.001	0.001	0.001	-

↑: Increment, *p < 0.05 and ***p < 0.001 comparing the mentioned group and its control group, aresults of ANOVA test between four groups, bresults of paired-t-test before and after the treatment.